Dimensional Fund Advisors
CABA icon

Dimensional Fund Advisors’s Cabaletta Bio CABA Stock Holding History

Dimensional Fund Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.01M Buy
967,195
+226,547
+31% +$745K ﹤0.01% 2646
2026
Q1 		$1.99M Buy
740,648
+288,609
+64% +$801K ﹤0.01% 2697
2025
Q4 		$990K Buy
+452,039
New +$1.12M ﹤0.01% 2861
2024
Q3 		– Sell
-17,516
Closed -$131K – 3359
2024
Q2 		$131K Sell
17,516
-7,859
-31% -$96.3K ﹤0.01% 3215
2024
Q1 		$433K Hold
25,375
– – ﹤0.01% 3070
2023
Q4 		$576K Sell
25,375
-53,330
-68% -$897K ﹤0.01% 3019
2023
Q3 		$1.2M Sell
78,705
-56,052
-42% -$766K ﹤0.01% 2879
2023
Q2 		$1.74M Hold
134,757
– – ﹤0.01% 2816
2023
Q1 		$1.11M Buy
+134,757
New +$1.26M ﹤0.01% 2878
2022
Q3 		– Sell
-19,863
Closed -$21K – 3495
2022
Q2 		$21K Hold
19,863
– – ﹤0.01% 3443
2022
Q1 		$40K Sell
19,863
-20,079
-50% -$52.5K ﹤0.01% 3475
2021
Q4 		$151K Buy
+39,942
New +$426K ﹤0.01% 3385

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Dimensional Fund Advisors's CABA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Cabaletta Bio (CABA) stake by 31% in Q2 2026, buying an estimated $745K and bringing the position to 967,195 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2646.

Dimensional Fund Advisors first reported a position in CABA in Q4 2021 and has held it in 12 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Dimensional Fund Advisors held 967,195 shares of Cabaletta Bio worth $3.01M as of Q2 2026.
  • Dimensional Fund Advisors bought 226,547 Cabaletta Bio shares in Q2 2026, an estimated $745K.
  • Cabaletta Bio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2646 holding.
  • Dimensional Fund Advisors first reported a position in Cabaletta Bio in Q4 2021 and has held it in 12 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.